LAX.SH
ARTEMIS MED SERVICE LTD·HOSPITALS 65.95·Healthcare Services Companies
Price
326.1
+1.49%52W Range
Market Cap
₹5,162.37 Cr
Traded: ₹32.02 Cr (0.62%) 0.0x
Free Float: ₹844.56 Cr (3.79% of FF traded)
Volume · 60D trend
9.74 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Profit | -- | +77.0% | +41.0% | -- | +33.0% | Decelerating |
| ROE | -- | +11.0% | +12.0% | -- | -- | Accelerating |
| Return | -- | +50.0% | +35.0% | +23.0% | -- | Decelerating |
| Sales | -- | +22.0% | +14.0% | -- | +15.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 287 | 279 | 272 | 275 | 255 | 240 | 232 | 241 | 223 | 225 | 219 | 225 | 210 | 195 | 187 | 187 |
| Expenses | 231 | 228 | 228 | 224 | 214 | 204 | 195 | 199 | 187 | 187 | 186 | 191 | 182 | 170 | 162 | 164 |
| Operating Profit | 56 | 52 | 45 | 51 | 41 | 36 | 37 | 42 | 36 | 38 | 33 | 34 | 28 | 26 | 26 | 23 |
| OPM % | 20.0% | 18.0% | 16.0% | 18.0% | 16.0% | 15.0% | 16.0% | 18.0% | 16.0% | 17.0% | 15.0% | 15.0% | 13.0% | 13.0% | 14.0% | 13.0% |
| Other Income | 5 | 8 | 4 | 8 | 7 | 12 | 9 | 7 | 4 | 2 | 2 | 2 | 1 | 2 | 1 | 1 |
| Interest | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 8 | 8 | 7 | 5 | 5 | 5 |
| Depreciation | 13 | 13 | 12 | 12 | 11 | 12 | 11 | 11 | 11 | 11 | 10 | 10 | 9 | 9 | 8 | 7 |
| Profit Before Tax | 43 | 40 | 30 | 39 | 30 | 29 | 27 | 31 | 22 | 20 | 16 | 19 | 13 | 14 | 13 | 13 |
| Tax % | 26.0% | 25.0% | 25.0% | 24.0% | 29.0% | 20.0% | 23.0% | 28.0% | 24.0% | 29.0% | 29.0% | 28.0% | 26.0% | 24.0% | 23.0% | 31.0% |
| Net Profit | 31 | 30 | 22 | 30 | 21 | 23 | 21 | 22 | 17 | 14 | 12 | 14 | 10 | 11 | 10 | 9 |
| Exceptional Items | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | 2.0 | 1.9 | 1.4 | 2.2 | 1.5 | 1.7 | 1.5 | 1.6 | 1.2 | 1.0 | 0.8 | 1.0 | 0.7 | 0.8 | 0.8 | 0.7 |
| Sales Growth (YoY) | 12.7% | 16.4% | 17.2% | 13.8% | 14.2% | 6.5% | 6.2% | 7.3% | 6.5% | 15.3% | 16.7% | 20.0% | 25.3% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 2.6% | -1.1% | 7.8% | 6.3% | 3.5% | -3.7% | 8.1% | -0.9% | 2.7% | -2.7% | 7.1% | 7.7% | 4.3% | 0.0% | -- |
| OP Growth (YoY) | 36.6% | 44.4% | 21.6% | 21.4% | 13.9% | -5.3% | 12.1% | 23.5% | 28.6% | 46.2% | 26.9% | 47.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | 7.7% | 15.6% | -11.8% | 24.4% | 13.9% | -2.7% | -11.9% | 16.7% | -5.3% | 15.2% | -2.9% | 21.4% | 7.7% | 0.0% | 13.0% | -- |
| Profit Growth (YoY) | -- | 30.4% | 19.2% | 34.6% | 27.6% | 62.4% | 79.0% | 63.8% | 69.8% | 33.8% | 10.5% | 48.9% | 16.6% | -20.0% | 61.0% | 11.5% |
| EPS Growth (YoY) | -- | 13.8% | -6.0% | 33.3% | 25.4% | 60.6% | 76.5% | 62.0% | 69.4% | 31.6% | 9.0% | 47.1% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 34.8% | -34.7% | 41.2% | -8.4% | 11.3% | -7.4% | 32.8% | 17.3% | 22.4% | -15.0% | 38.9% | -8.9% | 1.3% | 14.7% | -- |
| OP Margin | -- | 18.6% | 16.5% | 18.6% | 16.1% | 15.0% | 15.9% | 17.4% | 16.1% | 16.9% | 15.1% | 15.1% | 13.3% | 13.3% | 13.9% | 12.3% |
| Net Margin | -- | 10.8% | 8.1% | 10.9% | 8.2% | 9.6% | 9.1% | 9.1% | 7.6% | 6.2% | 5.5% | 6.2% | 4.8% | 5.6% | 5.3% | 4.8% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | 14.9% | 16.1% | 15.9% | 14.3% | 15.1% | 16.3% | 16.1% | 14.9% | 16.1% | 16.0% | 15.9% | 15.2% | 16.3% | 16.1% | 16.5% | 16.1% |
| P/S | 4.63 | 4.43 | 4.02 | 3.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 43.77 | 43.17 | 39.12 | 34.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.52 | 5.12 | 4.75 | 4.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of Earnings Conference Call - Q1 FY27
Analysts/ Institutional Investors' Conference - August 13, 2026
Un-audited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2026
Proceedings of the 22nd Annual General Meeting held on July 31, 2026
Voting Results of 22nd Annual General Meeting and Scrutinizer''s Report
Voting Results of Postal Ballot and Scrutinizer''s Report
Newspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
Commencement of Operations of Artemis Shanti Hospital, Raipur
Newspaper Publication - July 8, 2026
Letter to shareholders containing weblink of Annual Report for the financial year 2025-26
Business Responsibility and Sustainability Report for the financial year ended March 31, 2026
Annual Report for the financial year ended March 31, 2026 along with notice of 22nd Annual General Meeting.
Notice of 22nd Annual General Meeting and Annual Report for FY26
Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended June 30, 2026
Reminder Letter to holders of physical securities for furnishing of KYC details.
Notice of closure of Trading Window for the quarter ending June 30, 2026
Communication to Shareholders: Intimation on Tax Deduction at Source (TDS)/ withholding tax on Dividend for FY 2025-26
Newspaper Publication - June 23, 2026
Intimation for fixation of record date for payment of Final Dividend
Intimation of Annual General Meeting scheduled to be held on July 31, 2026
Newspaper Publication - Postal Ballot Notice
Notice of Postal Ballot dated June 4, 2026
Intimation of schedule of the Hospital Visit by Investors/ Analysts - June 19, 2026
Board of Directors approved the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds
Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2026 ,inter alia, to consider and approve the Notice of the ....
Annual Secretarial Compliance Report for the year ended March 31, 2026
Transcript of Earnings Conference Call - Q4 and FY26
Newspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
Audio Recording of Earnings Conference Call - Q4 and FY26
Intimation regarding completion of tenure of an Independent Director
Newspaper Publication - May 9, 2026
Monitoring Agency Report for the quarter ended March 31, 2026
The Board of Directors at its Meeting held on May 8, 2026 recommended final dividend of Re. 0.45 per share for FY26
Please find attached amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information
Appointment of an Additional Director in the Capacity of an Independent Director with effect form May 8, 2026
Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and year ended March 31, 2026
Earnings Presentation - Q4 FY26 and FY26
Press Release - May 8, 2026
Outcome of Board Meeting held on May 8, 2026
Intimation of Schedule of Earnings Conference Call-Q4 and FY26
Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financial ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026
Notice of closure of trading window for the quarter/year ending March 31, 2026
Newspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
Analysts/ Institutional Investors' Conference-March 23, 2026
Intimation regarding execution of Medical Services Agreement for VIMHANS, Nehru Nagar, New Delhi
Intimation of Schedule of Investors/Analysts Meeting - February 25, 2026
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Earnings Conference Call - Q3 and 9M FY26
Annual Reports
7Credit Ratings
6Concalls
15Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Held by ETFs
2 ETFs hold ARTEMISMED · sorted by weight
Held by Mutual Funds
6 schemes hold ARTEMISMED · sorted by weight